The mechanism of the increasing action of TA-993, a new 1,5- benzothiazepine derivative, on limb blood flow in anesthetized dogs: Selective suppression of sympathetic nerve activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1167-1173

  Kaburaki, Minako ^a   Yabana, Hideo ^a   Doi, Hisayoshi ^a   Nagata, Koichi ^a   Narita, Hiroshi ^a   Murata, Sakae ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM IODIDE; 3 ACETOXY 5 [2 (DIMETHYLAMINO)ETHYL] 2,3 DIHYDRO 8 METHYL 2 (4 METHYLPHENYL) 1,5 BENZOTHIAZEPIN 4(5H) ONE MALEATE; ACETYLCHOLINE; ATROPINE; BENZOTHIAZEPINE DERIVATIVE; HEXAMETHONIUM; ISOPRENALINE; PHENTOLAMINE; PHENYLEPHRINE; PROPRANOLOL; TALIPEXOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOG; FEMALE; FEMORAL ARTERY FLOW; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; LIMB BLOOD FLOW; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE;

ANIMALS; DILTIAZEM; HINDLIMB; PERFUSION; PLATELET AGGREGATION INHIBITORS; REGIONAL BLOOD FLOW; SYMPATHETIC NERVOUS SYSTEM;

EID: 0033022378     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fujiwara S, Ito Y, Itoh T, Kuriyama H and Suzuki H (1982) Diltiazem-induced vasodilation of smooth muscle cells of the canine basilar artery. Br J Pharmacol 75:455-467.
2. Ito Y, Kuriyama H and Suzuki H (1978) The effects of diltiazem (CRD-401) on the membrane and mechanical properties of vascular smooth muscles of the rabbit. Br J Pharmacol 64:503-510.
3. Kaburaki M, Doi H, Narita H, Odawara A, Yasoshima A and Murata S (1998a) Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis. J Cardiovasc Pharmacol 31:471-478.
4. Kaburaki M, Inoue H, Doi H, Yasuhara M and Narita H (1998b) Cardiovascular effects of 1,5-benzothiazepine derivatives having a l-cis and d-cis configuration in anesthetized dogs. Biol Pharm Bull 20:50-55.
5. Kaburaki M, Narita H, Yabana H, Karasawa T, Doi H and Murata S (1998c) Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs. J Cardiovasc Pharmacol 31:240-247.
6. Kikkawa K, Murata S and Nagao T (1988) Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries. Arzneim-Forsch/Drug Res 38:526-531.
7. Murata S, Kikkawa K, Yabana H and Nagao T (1988) Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs. Arzneim-Forschl Drug Res 38:521-525.
8. Nagao T, Ikeo T and Sato M (1977) Influence of calcium ions on responses to diltiazem in coronary arteries. Jpn J Pharmacol 27:330-332.
9. Narita H, Kaburaki M, Doi H, Yasoshima A and Murata S (1995) Antithrombotic effect of TA-993, a novel 1,5-benzothiazepine derivative, in conscious rats. Jpn J Pharmacol 68:397-404.
10. Odawara A, Kikkawa K, Katoh M, Toryu H, Shimazaki T and Sasaki Y (1996) Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation. Circ Res 78:643-649.
11. Rosenthal SJ, Lamb IH, Schroeder JS and Ginsburg R (1983) Long-term efficacy of diltiazem for control of symptoms of coronary artery spasm. Circ Res 52 (Suppl I):153-157.
12. Sato M, Nagao T, Yamaguchi I, Nakajima H and Kiyomoto A (1971) Pharmacological studies on a new 1,5-benzothiazepine derivative (CRD-401). I. Cardiovascular actions. Arzneim-Forsch/Drug Res 21:1338-1343.